XML 42 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 28, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of stock based compensation expense

Stock-based compensation expense included in the Company's consolidated financial statements for the three and six months ended June 28, 2020 and June 30, 2019 was as follows (in thousands):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 28,

2020

 

 

June 30,

2019

 

 

June 28,

2020

 

 

June 30,

2019

 

Cost of revenue

 

$

31

 

 

$

18

 

 

$

43

 

 

$

44

 

Research and development

 

 

486

 

 

 

532

 

 

 

22

 

 

 

1,187

 

Selling, general and administrative

 

 

224

 

 

 

241

 

 

 

278

 

 

 

511

 

Total costs and expenses

 

$

741

 

 

$

791

 

 

$

343

 

 

$

1,742

 

Summary of the activity in the shares available for grant

The following table summarizes the activity in the shares available for grant under the 2019 Plan during the six months ended June 28, 2020 (in thousands):

 

 

 

Shares Available for Grants

 

 

 

2019 Plan

 

Balance at December 29, 2019

 

 

272

 

Authorized shares

 

 

550

 

RSUs granted

 

 

(289

)

PRSU's granted

 

 

(129

)

Options cancelled

 

 

49

 

RSUs forfeited or expired

 

 

163

 

PRSUs forfeited or expired

 

 

42

 

Balance at June 28, 2020

 

 

658

 

Summary of stock options outstanding and stock option activity and the related weighted average exercise price

The following table summarizes stock options outstanding and stock option activity under the 2009 Plan and the 2019 Plan, and the related weighted average exercise price, for the six months ended June 28, 2020:

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Term

 

 

Aggregate

Intrinsic

Value

 

 

 

(in thousands)

 

 

 

 

 

 

(in years)

 

 

(in thousands)

 

Balance outstanding at December 29, 2019

 

 

185

 

 

$

32.09

 

 

3.32

 

 

 

 

Forfeited or expired

 

 

(48

)

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance outstanding at June 28, 2020

 

 

137

 

 

$

29.51

 

 

 

3.81

 

 

$

 

Exercisable at June 28, 2020

 

 

134

 

 

$

29.93

 

 

 

3.75

 

 

$

 

Vested and expected to vest at June 28, 2020

 

 

137

 

 

$

29.52

 

 

 

3.81

 

 

$

 

 

Summary of Restricted Stock Units Activity

A summary of activity for the Company's RSUs for the six months ended June 28, 2020 is as follows:

 

 

 

RSUs & PRSUs Outstanding

 

 

 

Number of

Shares

 

 

Weighted

Average

Grant Date

Fair Value

 

 

 

(in thousands)

 

 

 

 

 

Nonvested at December 29, 2019

 

 

377

 

 

$

12.55

 

Granted

 

 

418

 

 

 

4.50

 

Vested

 

 

(119

)

 

 

10.21

 

Forfeited

 

 

(205

)

 

 

 

Nonvested at June 28, 2020

 

 

471

 

 

$

7.99

 

Summary of the fair value of rights issued pursuant to ESPP

The fair value of rights issued pursuant to the Company's 2009 ESPP was estimated on the commencement date of each offering period using the following weighted average assumptions:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 28,

2020

 

 

June 30,

2019

 

 

June 28,

2020

 

 

June 30,

2019

 

Expected term (months)

 

 

6.08

 

 

 

6.00

 

 

 

6.08

 

 

 

6.00

 

Risk-free interest rate

 

 

0.15

%

 

 

2.40

%

 

 

0.15

%

 

 

2.40

%

Volatility

 

 

88.35

%

 

 

53.77

%

 

 

88.35

%

 

 

53.77

%

Dividend yield